ARTICLE
Zero Hero: Disclaiming Disputed Term Renders Dispute Moot
May 5, 2021
Read time: 1 min
Main /
Capabilitiesmain /
InsightsARTICLE
May 5, 2021
Read time: 1 min

INTERNATIONAL NEWS / REPORT
May 2021
Read time: 3 min
The global healthcare industry has had the most challenging year in living memory. But 2021 is a new year. Alongside new challenges, such as whether or not healthcare employers can or should make COVID-19 vaccines mandatory for employees, and the uncertainty surrounding the transfer of European health data post-Schrems II, there are also many new opportunities.
Sovereign Wealth Funds are increasingly seeing the health sector as an attractive investment market, and Social Impact Bonds have emerged as an excellent financing option for development projects that might otherwise find it hard to attract initial funding.
Healthcare companies still, of course, need to pay close attention to their commercial operations. As the market evolves to meet the new normal of an increasingly online and app-centric world, the need for robust agreements with software developers becomes ever more important. And the sector will always be the target of investigations into excessive pricing, and subject to developments relating to key tools such as Supplementary Protection Certificates. But the time has come to be cautiously optimistic and to look to the future of healthcare
ARTICLE
May 4, 2021
Read time: 1 min

ARTICLE
May 4, 2021
Read time: 1 min

ARTICLE
May 1, 2021
Read time: 2 min
Comment on BVerfG v. 19.6.2020 – 1 BvR 842/17
A decision review by Dr. Gudrun Germakowski and Dr. Sandra Urban-Crell, published in Recht der Arbeit (RdA), Issue 2, 2021, pp. 123-126.
Deal announcement
McDermott advises NORD Holding on the acquisition of alfavet Group

ARTICLE / CLIENT ALERT
April 30, 2021
Read time: 2 min
Since the last amendment of the SARS-CoV-2 Occupational Health and Safety Ordinance (Corona-ArbSchV), companies must offer their employees a test at least twice per calendar week with regard to direct pathogen detection of the coronavirus. Bettina Holzberger and Dr. Philip Uecker explain the most important key points around the obligation to offer and test, documentation, costs and working time.
Deal announcement
McDermott advises NORD Holding on the acquisition of alfavet Group

ARTICLE
April 29, 2021
Read time: 1 min

ARTICLE
May 2021
Read time: 1 min

Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott Will & Schulte via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott Will & Schulte from representing any other person or firm in any matter; and will not obligate McDermott Will & Schulte to keep confidential the information you provide. McDermott Will & Schulte cannot enter into an attorney-client relationship with you until McDermott Will & Schulte has determined that doing so will not create a conflict of interest and until you and McDermott Will & Schulte have entered into a written agreement or engagement letter that sets forth the terms of our relationship.